Recent research links the widely used asthma drug Singulair to severe mental health issues, including suicidal thoughts. The FDA has issued a 'black box' warning following reports of neuropsychiatric ...
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a drug-drug interaction with an antifungal during a phase 2 trial. The Big Pharma ...